These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21337312)

  • 1. Calciphylaxis: a still unmet challenge.
    Brandenburg VM; Cozzolino M; Ketteler M
    J Nephrol; 2011; 24(2):142-8. PubMed ID: 21337312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.
    Hayden MR; Tyagi SC; Kolb L; Sowers JR; Khanna R
    Cardiovasc Diabetol; 2005 Mar; 4():4. PubMed ID: 15777477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.
    Schlieper G; Brandenburg V; Ketteler M; Floege J
    Nat Rev Nephrol; 2009 Sep; 5(9):539-43. PubMed ID: 19701230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcific uremic arteriolopathy in hemodialyzed patients.
    Checheriţă IA; Smarandache D; Rădulescu D; Peride I; Bratu O; Ciocâlteu A; Sebe I; Lascăr I
    Chirurgia (Bucur); 2013; 108(5):736-40. PubMed ID: 24157123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
    Santos PW; He J; Tuffaha A; Wetmore JB
    Int Urol Nephrol; 2017 Dec; 49(12):2247-2256. PubMed ID: 29058165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism.
    Kyritsis I; Gombou A; Griveas I; Agroyannis I; Retsa K; Agroyannis B
    Int J Artif Organs; 2008 Aug; 31(8):742-4. PubMed ID: 18825648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcific uremic arteriolopathy: a call for action.
    Brandenburg VM; Cozzolino M; Mazzaferro S
    Semin Nephrol; 2014 Nov; 34(6):641-7. PubMed ID: 25498382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of calcific uremic arteriolopathy with sodium thiosulfate in a renal transplant recipient.
    Li JY; Yong TY; Choudhry M; Rao N; Milton C; Juneja R; Barbara JA; Passaris G
    Ren Fail; 2012; 34(5):645-8. PubMed ID: 22364415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calciphylaxis].
    Brandenburg VM; Martin H; Sohn CM; Ketteler M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):347-51. PubMed ID: 25734678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calciphylaxis: an enigma to the nephrologist].
    Barbera V; Di Lullo L; Otranto G; Barbera G; Santoboni A
    G Ital Nefrol; 2012; 29(6):674-82. PubMed ID: 23229665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
    Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcific uremic arteriolopathy - treatment with sodium thiosulfate].
    Vyskočilová M; Svojanovský J; Blaštíková J; Dvořáková G; Souček M
    Vnitr Lek; 2015 Feb; 61(2):166-72. PubMed ID: 25813263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcific uraemic arteriolopathy: an update.
    Rogers NM; Coates PT
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):629-34. PubMed ID: 18941358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary approach to calcific uremic arteriolopathy.
    Nigwekar SU
    Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):531-7. PubMed ID: 26371529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.
    Hayden MR; Goldsmith D; Sowers JR; Khanna R
    Int Urol Nephrol; 2008; 40(2):443-51. PubMed ID: 18369733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.
    Colboc H; Moguelet P; Bazin D; Carvalho P; Dillies AS; Chaby G; Maillard H; Kottler D; Goujon E; Jurus C; Panaye M; Frochot V; Letavernier E; Daudon M; Lucas I; Weil R; Courville P; Monfort JB; Chasset F; Senet P;
    JAMA Dermatol; 2019 Jul; 155(7):789-796. PubMed ID: 31116362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success of small-dose fractionated sodium thiosulfate in the treatment of calciphylaxis in a peritoneal dialysis patient.
    Lu Y; Shen L; Zhou L; Xu D
    BMC Nephrol; 2022 Jan; 23(1):4. PubMed ID: 34979980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcific uremic arteriolopathy].
    Dusilová Sulková S
    Vnitr Lek; 2015 Feb; 61(2):97-100. PubMed ID: 25989634
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
    Malbos S; Ureña-Torres P; Bardin T; Ea HK
    Joint Bone Spine; 2016 Jan; 83(1):89-92. PubMed ID: 26494591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: risk factors, diagnosis, and treatment.
    Nigwekar SU; Kroshinsky D; Nazarian RM; Goverman J; Malhotra R; Jackson VA; Kamdar MM; Steele DJ; Thadhani RI
    Am J Kidney Dis; 2015 Jul; 66(1):133-46. PubMed ID: 25960299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.